MiMedx Group (MDXG) Reports In-Line Q3 EPS

MiMedx Group (NASDAQ: MDXG) reported Q3 EPS of $0.06, in-line with the analyst estimate of $0.06. Revenue for the quarter came in at $64.4 million versus the consensus estimate of $63.18 million.

For earnings history and earnings-related data on MiMedx Group (MDXG) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Keefe, Bruyette & Woods Downgrades Crescent BDC (CCAP) to Market Perform
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c